Search Results
May 13, 2026, 08:04 ET ERS Genomics and Aurigene Sign CRISPR/Cas9 License Agreement to Advance Precision Genome Editing in Drug Discovery
we are pleased to collaborate with ERS Genomics. Access to ERS' foundational CRISPR/Cas9 intellectual property enables us to integrate cutting-edge gene editing capabilities into our discovery workflows. Our customers will benefit from faster, more precise target validation, improved disease model generation,
More news about: ERS Genomics
May 13, 2026, 08:00 ET Andelyn Biosciences Receives Dark Horse Consulting Certification of Gene Therapy Manufacturing Systems and Capabilities within its Initiative for Certification of Manufacturing Capabilities (ICMC™) Program
company supports innovators in advancing gene therapies from development through clinical and commercial manufacturing."Andelyn's receipt of the ICMC certification reflects the strength of the teams, culture, and infrastructure we have built to support complex gene therapy programs," said Wade Macedone,
More news about: Andelyn Biosciences
May 12, 2026, 22:46 ET Shield AI expands Hivemind maritime autonomy in Taiwan with Thunder Tiger partnership
We see this partnership as an opportunity to advance Taiwan's defense industrial base and deliver more capable, autonomous systems to forces," said Gene Su, board director and general manager of Thunder Tiger Corp.Hivemind is Shield AI's core artificial intelligence software that enables systems
More news about: Shield AI
May 12, 2026, 16:10 ET Ribo gibt strategische Zusammenarbeit mit Insilico Medicine bekannt, um die Entwicklung von siRNA-Medikamenten mithilfe von KI voranzutreiben
Durch die Nutzung des RNAi-Mechanismus sind siRNA-Medikamente in der Lage, pathogene Gene präzise stillzulegen. Mit ihren Kernvorteilen wie einem extrem breiten Zielspektrum, digitalen Designmöglichkeiten, kurzen Entwicklungszyklen und einer
More news about: Suzhou Ribo Life Science Co., Ltd.
May 12, 2026, 12:00 ET Caring Cross Announces Promising Clinical Data with Single-Dose anti-HIV CAR-T Cell Therapy
California, Davis (UC Davis) – UC Davis is one of the most academically comprehensive universities in the field of cell and gene therapy. We are known for our outstanding cell and gene therapy programs across many areas of medicine focused on curing complex disorders through scientific innovations. For more
More news about: Caring Cross
May 12, 2026, 11:00 ET Porton Advanced and Dark Horse Consulting Group Announce Memorandum of Understanding Providing A Streamlined Path to Conducting IITs in China
Memorandum of Understanding (MOU) to establish a strategic collaboration aimed at accelerating the development and clinical translation of cell and gene therapies globally. This partnership unites DHCG's comprehensive regulatory, CMC, nonclinical, clinical, quality & compliance, supply chain,
More news about: Porton Advanced
May 12, 2026, 10:30 ET New Research Funding From Solve M.E. Advances Innovative ME/CFS and Long Covid Studies Toward Treatments
sequencing to analyze all 3 billion genetic positions in participants, providing 3,000x more data than standard GWAS. The study could reveal many more genes, gene-regulation elements, and biological pathways that affect ME/CFS and Long Covid risk, advance efforts to identify new biomarkers for disease subtypes,
More news about: Solve M.E.
May 12, 2026, 09:53 ET Enliven Therapeutics Announces Oral Presentation at the EHA 2026 Congress Featuring Additional Positive Phase 1 Clinical Trial Data for ELVN-001 in CML
ET.ELVN-001 is a potent, highly selective, potentially best-in-class small molecule kinase inhibitor designed to specifically target the BCR::ABL1 gene fusion, the oncogenic driver for patients living with CML. Data presented at EHA will be from the ongoing ENABLE Phase 1 clinical trial, which enrolled
More news about: Enliven Therapeutics, Inc.
May 12, 2026, 09:30 ET Lung Cancer Research Foundation Grants Team Science Award Focused on Understanding and Treating Lung Cancers with HER2 Mutations
the leading cause of cancer-related death worldwide. A subset of patients with non–small cell lung cancer (NSCLC) have tumors driven by mutations in a gene called HER2. While recent approvals of HER2-targeted tyrosine kinase inhibitors (TKIs) have represented major progress, most patients eventually relapse
More news about: Lung Cancer Research Foundation
May 12, 2026, 09:00 ET Porton Advanced Stem Cell Exosomes Granted INCI Status, Advancing into Global Cosmetic Ingredient Market
services into diverse areas, including exosome raw materials and cosmetic applications.Leveraging its GMP-compliant platform built in the cell and gene therapy field, Porton Advanced has established robust manufacturing and quality control systems to ensure high purity, high activity, and high stability
More news about: Porton Advanced
May 12, 2026, 09:00 ET Harrington Discovery Institute Announces 2026 Scholar-Innovator Award Recipients
to Combat Brain Swelling in Malignant TumorsSenthil Velan Bhoopalan, MD – St. Jude Children's Research HospitalAdvanced Gene Therapy for a Rare Genetic Anemia (Diamond-Blackfan)Elliot Chaikof, MD, PhD – Beth Israel Deaconess Medical CenterTherapies
More news about: Harrington Discovery Institute
May 12, 2026, 08:57 ET Apex Geotech Solutions Appoints Gerald Mosley as Chief Executive Officer
strong track record of scaling manufacturing platforms, expanding operational capabilities, and driving commercial and financial performance.Gene Swindell will continue as President of Apex, working closely with Mr. Mosley to advance the company's strategic and operational priorities while maintaining
More news about: Gemspring Capital
May 12, 2026, 08:47 ET Project MFG National Championship Brings Top Advanced Manufacturing Students to Alabama
industry partners — a key part of Project MFG's workforce development model. These partners include Mastercam, Mitutoyo, Haas Automation, ZEISS, and the Gene Haas Foundation. The national championship comes as the U.S. manufacturing industry faces a projected 1.9 million unfilled jobs by 2033,
More news about: Project MFG
May 12, 2026, 08:00 ET Andelyn Biosciences Launches LVV Curator® Platform, Bringing Proven Viral Vector Platform Pedigree to Lentiviral Vector Manufacturing for Cell Therapies
andelynbio.com/lvv-curator-platform.About Andelyn BiosciencesAndelyn Biosciences is a full-service cell and gene therapy CDMO focused on the development, characterization, and production of viral vectors for gene therapy. With more than 20 years of experience, Andelyn's deep scientific expertise has resulted in
More news about: Andelyn Biosciences
May 12, 2026, 08:00 ET 28bio Launches CNS-3D Myelinated Organoids to Predict Therapeutic Efficacy
functional deficits across neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's. This challenge is amplified in cell and gene therapies, where restoring or preserving myelin requires precise targeting of oligodendrocytes and sustained functional repair."The premarket
More news about: 28bio
May 12, 2026, 07:00 ET Castle Biosciences' AdvanceAD-Tx™ Test Receives 2026 MedTech Breakthrough Award for Genomics Innovation
meaningful progress and improving patient care across the global health and medical technology industry. AdvanceAD-Tx is Castle's clinically validated gene expression profile (GEP) test designed to guide systemic treatment decision making in patients 12 and older with moderate-to-severe atopic dermatitis
More news about: Castle Biosciences, Inc.
May 12, 2026, 05:55 ET ATUM's New Lock-In™ Platform Solves Bispecific Mispairing
www.atum.bio.About ATUMATUM is a fully integrated biotechnology contract research organization (CRO) providing services for gene design, protein engineering, and cell line development. By combining machine learning, synthetic biology, and proprietary expression technologies, ATUM
More news about: ATUM
May 12, 2026, 04:13 ET Porton Advanced Stem Cell Exosomes Granted INCI Status, Advancing into Global Cosmetic Ingredient Market
services into diverse areas, including exosome raw materials and cosmetic applications.Leveraging its GMP-compliant platform built in the cell and gene therapy field, Porton Advanced has established robust manufacturing and quality control systems to ensure high purity, activity, and stability of its
More news about: Porton Advanced
May 12, 2026, 03:00 ET SkylineDx to Showcase New Cutaneous Squamous Cell Carcinoma Findings at 83rd Society for Investigative Dermatology Annual Meeting
somatic alterations, promote keratinocyte carcinogenesis.E-Poster:"Gene expression predicts metastatic risk in low-risk cutaneous squamous cell carcinoma."SCCore GEP, a novel gene expression signature for CSCC, addresses the need for improved metastatic risk stratification,
More news about: SkylineDx
May 12, 2026, 02:59 ET DNA 'barcodes' help NUS researchers pinpoint gold nanoparticles that can strike cancer at its power source
nanoparticle formulation in a combined treatment strategy. The particles were engineered to deliver small interfering RNA (siRNA) that disrupts mitochondrial gene expression, while also generating heat under near-infrared light through photothermal therapy.This dual approach produced strong anticancer effects
More news about: National University of Singapore
May 11, 2026, 13:41 ET New AI tool predicts how cells choose their future, helping uncover hidden drivers of development
complementary strengths…high-resolution gene regulatory circuitry from our lab and dynamic trajectory and network modeling from Fabian's team," Sauka-Spengler said. "RegVelo emerged from integrating those two views into one framework." What are Gene Regulatory Networks?
More news about: Stowers Institute for Medical Research
May 11, 2026, 13:33 ET DNA Synthesis Market to Reach $30.4 billion, Globally, by 2035 at 18.2% CAGR: Allied Market Research
primary drivers is the rapid advancement of gene editing technologies such as CRISPR-Cas systems, which require custom-designed DNA sequences for guide RNAs and engineered constructs, significantly increasing demand for synthetic DNA. Additionally, the expansion of gene therapy and personalized medicine is
More news about: Allied Market Research
May 11, 2026, 12:41 ET DNA Polymerase Market to Reach USD 725.8 Million by 2035 as Molecular Diagnostics and High-Fidelity Enzymes Accelerate Precision Genomics
polymerases have become foundational tools in modern genomics, enabling critical applications such as PCR-based diagnostics, gene sequencing, forensic analysis, synthetic biology, and gene-editing workflows. The increasing prevalence of infectious diseases, genetic disorders, and cancer is significantly amplifying
More news about: Future Market Insights
May 11, 2026, 12:15 ET Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels
for this study. WES provides a true measurement of TMB by interrogating every protein-coding gene mutation that may create a neoantigen, in comparison to targeted panels that only estimate TMB with incomplete gene coverage.Key findings include:The analysis compared WES-measured
More news about: Caris Life Sciences
May 11, 2026, 11:48 ET /C O R R E C T I O N -- Anixa Biosciences, Inc./
Updated data were presented on May 7, 2026, at the International Society for Cell & Gene Therapy ("ISCT") 2026 Annual Meeting by Cheryl Cox, MHA, Operations Director of the Cell Therapies and Gene Expression Engineering Facility at Moffitt Cancer Center. The presentation, titled "A Phase I
More news about: Anixa Biosciences, Inc.